Quick answer: to convert a retatrutide dose from mg to syringe units, divide the vial size by the water you add to get the concentration, then divide the dose by the concentration. On a U-100 insulin syringe, 1 mL = 100 units. Example: a 10 mg vial + 2 mL bacteriostatic water = 5 mg/mL, so 2 mg = 0.4 mL = 40 units.
Retatrutide (LY3437943) is an investigational once-weekly triple agonist of the GLP-1, GIP and glucagon receptors. It is not approved by any regulatory agency, and this page is a research reference that explains the math and the published trial data. It is not dosing advice. Use the calculator below for any vial size.
Retatrutide Dosage Calculator
Enter the vial size, the bacteriostatic water you add and the dose to see the volume and syringe units. Works for any vial size.
Math only: units = dose ÷ (vial mg ÷ water mL) × 100 on a U-100 insulin syringe. This calculator converts amounts and does not recommend a dose. Retatrutide is an investigational compound and is not approved by any regulatory agency.
Retatrutide Units Chart by Vial Size
The table shows U-100 syringe units for common vial sizes, each mixed with 2 mL of bacteriostatic water. If you use a different amount of water, use the calculator above.| Dose | 5 mg vial (2.5 mg/mL) | 10 mg vial (5 mg/mL) | 20 mg vial (10 mg/mL) | 40 mg vial (20 mg/mL) |
|---|---|---|---|---|
| 1 mg | 40 units | 20 units | 10 units | 5 units |
| 2 mg | 80 units | 40 units | 20 units | 10 units |
| 4 mg | 160 units* | 80 units | 40 units | 20 units |
| 8 mg | 320 units* | 160 units* | 80 units | 40 units |
| 12 mg | 480 units* | 240 units* | 120 units* | 60 units |
Retatrutide Dosing Chart (Clinical Trial Doses)
The main published dose data come from the phase 2 obesity trial (Jastreboff et al., NEJM 2023). Participants received retatrutide once weekly for 48 weeks. The higher-dose groups started at 2 mg or 4 mg and were increased stepwise to their target dose.| Target weekly dose | Escalation steps | Mean body-weight change at 48 weeks |
|---|---|---|
| 1 mg | 1 mg throughout | −8.7% |
| 4 mg | 2 → 4 mg, or 4 mg throughout | −17.1% (both groups combined) |
| 8 mg | 2 → 4 → 8 mg, or 4 → 8 mg | −22.8% (both groups combined) |
| 12 mg | 2 → 4 → 8 → 12 mg | −24.2% |
| Placebo | – | −2.1% |

How to Calculate Retatrutide Dosage by Hand
Research peptides usually come as a lyophilized (freeze-dried) powder that is reconstituted with bacteriostatic water. The calculation has four steps.Step 1: Note the vial strength
Example: a 10 mg vial.Step 2: Note the water added
Example: 2 mL of bacteriostatic water.Step 3: Work out the concentration
10 mg ÷ 2 mL = 5 mg per mLStep 4: Convert the dose to volume and units
For a 2 mg amount: 2 mg ÷ 5 mg/mL = 0.4 mL. On a U-100 insulin syringe, 0.4 mL × 100 = 40 units. The same formula works for any vial: units = dose (mg) ÷ (vial mg ÷ water mL) × 100. For other peptides, use the general peptide calculator.Retatrutide Half-Life
In the phase 1b trial (Urva et al., The Lancet 2022), retatrutide’s half-life was about 6 days, and its pharmacokinetics were dose-proportional. That half-life is why the trials use once-weekly dosing. As a simplified estimate after a single dose, about half remains after ~6 days, a quarter after ~12 days and about 12% after ~18 days. With repeated weekly doses, levels build up to a steady state over roughly 4–5 half-lives (about a month).How Retatrutide Works
Retatrutide activates three receptors at once:- GLP-1 receptor: appetite and insulin secretion
- GIP receptor: glucose metabolism and fat regulation
- Glucagon receptor: energy expenditure and fat breakdown